Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Valtis YK"'
Autor:
Valtis YK; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Nemirovsky D; Memorial Sloan-Kettering Cancer Center, New York, New York, United States., Derkach A; Memorial Sloan-Kettering Cancer Center, New York, New York, United States., Sharan S; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Kabel CC; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Ortiz R; Mount Sinai Morningside West, New York, New York, United States., Thompson MC; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Roeker LE; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Geyer MB; Memorial Sloan Kettering Cancer Center, New York, New York, United States.
Publikováno v:
Blood advances [Blood Adv] 2024 Aug 09. Date of Electronic Publication: 2024 Aug 09.
Autor:
Aldoss I; City of Hope National Medical Center, Duarte, California, United States., Roloff GW; The University of Chicago, Chicago, Illinois, United States., Faramand RG; Moffitt Cancer Center, Tampa, Florida, United States., Kopmar NE; University of Washington, Seattle, Washington, United States., Lin C; Duke University School of Medicine, Durham, North Carolina, United States., Advani AS; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, United States., Dekker SE; Fred Hutchinson Cancer Center / University of Washington, Seattle, Washington, United States., Gupta VK; UCLA, Los Angeles, California, United States., O'Connor TE; Loyola University Medical Center, Maywood, Illinois, United States., Jeyakumar N; Stanford University, Stanford, California, United States., Muhsen IN; Baylor College of Medicine, Houston, Texas, United States., Valtis YK; Memorial Sloan Kettering Cancer Institute, New York city, New York, United States., Zhang A; Stanford University School of Medicine, Palo Alto, California, United States., Miller K; Stanford University School of Medicine, Stanford, California, United States., Sutherland KC; Stanford University School of Medicine, Stanford, California, United States., Dykes KC; University of California, San Diego, La Jolla, California, United States., Ahmed M; Cedars Sinai Medical Center, Houston, Texas, United States., Chen EC; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Zambrano H; Sarah Cannon Cancer Institute, Nashville, Tennessee, United States., Bradshaw D; Georgia Cancer Center at Augusta University, Augusta, Georgia, United States., Mercadal S; University of Utah/ Huntsman Cancer Hospital, Salt Lake City, Utah, United States., Schwartz MS; University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States., Tracy SI; University of Minnesota, Minneapolis, Minnesota, United States., Dholaria B; Vanderbilt University Medical Center, Nashville, Tennessee, United States., Kubiak MJ; Georgia Cancer Center of Augusta University, Augusta, Georgia, United States., Mukherjee A; Oncology Hematology Care, Cincinnati, Ohio, United States., Majhail NS; Sarah Cannon Cancer Institute, Nashville, Tennessee, United States., Battiwalla M; Sarah Cannon Transplant and Cellular Therapy Network, HCA Healthcare, Nashville, Tennessee, United States., Mountjoy L; Colorado Blood Cancer Institute, Denver, Colorado, United States., Malik SA; Texas Transplant Institute, Austin, Texas, United States., Mathews J; Sarah Cannon Transplant and Cellular Therapy Program, Dallas, Texas, United States., Shaughnessy PJ; Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital San Antonio, TX, San Antonio, Texas, United States., Logan A; University of California San Francisco, San Francisco, California, United States., Ladha A; University of Southern California, Los Angeles, California, United States., Stefan M; Cleveland Clinic, Cleveland, Ohio, United States., Guzowski C; Northside Hospital, Atlanta, Georgia, United States., Hoeg RT; UC Davis, Sacramento, California, United States., Hilal T; Mayo Clinic, Phoenix, Arizona, United States., Moore J; University of Rochester Medical Center, Rochester, New York, United States., Connor M; University of Pennsylvania, Philadelphia, Pennsylvania, United States., O'Dwyer KM; University of Rochester Medical Center, Rochester, New York, United States., Hill LC; Baylor College of Medicine, Houston, Texas, United States., Tsai SB; Loyola University Medical Center, Maywood, Illinois, United States., Sasine JP; Cedars-Sinai Medical Center, Los Angeles, California, United States., Solh MM; The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia, United States., Lee CJ; University of Utah; Huntsman Cancer Institute, United States., Kota V; Georgia Cancer Center at Augusta University, Augusta, Georgia, United States., Koura D; University of California, San Diego, La Jolla, California, United States., Veeraputhiran M; University of Arkansas Medical Center, Little Rock, Arkansas, United States., Blunk B; Sarah Cannon Cancer Institute, Nashville, Tennessee, United States., Oliai C; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States., Leonard JT; Oregon Health Sciences, Portland, Oregon, United States., Frey NV; Hospital of the University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, United States., Park JH; Memorial Sloan-Kettering Cancer Center, New York, New York, United States., Luskin MR; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Bachanova V; University of Minnesota, Minneapolis, Minnesota, United States., Galal A; Atlantic Health Network, Morristown, New Jersey, United States., Bishop MR; University of Chicago, Chicago, Illinois, United States., Stock W; University of Chicago, Chicago, Illinois, United States., Cassaday RD; Fred Hutchinson Cancer Center, Seattle, Washington, United States., Pullarkat VA; City of Hope Medical Center, Duarte, California, United States., Shah BD; Moffitt Cancer Center, Tampa, Florida, United States., Muffly L; Stanford University, Stanford, California, United States.
Publikováno v:
Blood advances [Blood Adv] 2024 Aug 02. Date of Electronic Publication: 2024 Aug 02.
Autor:
Valtis YK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Flamand Y; Department of Data Science, Dana Farber Cancer Institute, Boston, MA, USA., Shimony S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Place AE; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Pediatric Hematology Oncology, Boston Children's Hospital, Boston, MA, USA., Silverman LB; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Pediatric Hematology Oncology, Boston Children's Hospital, Boston, MA, USA., Vrooman LM; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Pediatric Hematology Oncology, Boston Children's Hospital, Boston, MA, USA., Brunner AM; Department of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA., Sallan SE; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Pediatric Hematology Oncology, Boston Children's Hospital, Boston, MA, USA., Wadleigh M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. marlise_luskin@dfci.harvard.edu.
Publikováno v:
Leukemia [Leukemia] 2024 Mar; Vol. 38 (3), pp. 482-490. Date of Electronic Publication: 2024 Jan 05.
Autor:
Shimony S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Hematology Department, Rabin Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Flamand Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Valtis YK; Department of Medicine, Memorial Sloan Kettering Cancer Institute, New York, NY., Place AE; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA., Silverman LB; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA., Vrooman LM; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA., Brunner AM; Leukemia Department, Hematology/Oncology, Massachusetts General Hospital, Boston, MA., Sallan SE; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Wadleigh M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2023 Sep 26; Vol. 7 (18), pp. 5234-5245.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2023 Jun 29; Vol. 388 (26), pp. e81.
Autor:
Wong W; Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA., Dickerson JC; Department of Medicine (Hematology and Oncology), Stanford University, Stanford, CA, USA., Valtis YK; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Habet M; Medical Oncology, Karl Heusner Memorial Hospital, Belize City, Belize., Bernard M; Nursing Department, Karl Heusner Memorial Hospital, Belize City, Belize., Kelly L; Nursing Department, Karl Heusner Memorial Hospital, Belize City, Belize., Lattin J; Department of Medicine, Saint Louis University School of Medicine, St. Louis, MO, USA., Garrity P; Global Oncology, Inc., Oakland, CA, USA., Sood R; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Ohanian A; Department of Medicine, UCSF School of Medicine, San Francisco, CA, USA., Chege MW; Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA., Bhatt AS; Global Oncology, Inc., Oakland, CA, USA.; Department of Medicine (Hematology, Blood and Marrow Transplantation) and of Genetics, Director of Global Oncology for the Stanford Center for Innovation in Global Health, Stanford University, Stanford, CA, USA., Huang FW; Global Oncology, Inc., Oakland, CA, USA.; Division of Hematology and Oncology, Department of Medicine, San Francisco Veterans Affairs Medical Center, University of California San Francisco, San Francisco, CA, USA.; Department of Urology, University of California San Francisco, San Francisco, CA, USA.; Chan Zuckerberg Biohub, San Francisco, CA, USA., Yacab R; Medical Oncology, Karl Heusner Memorial Hospital, Belize City, Belize.
Publikováno v:
The oncologist [Oncologist] 2023 Jun 02; Vol. 28 (6), pp. e350-e358.
Autor:
Shimony S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Rabin Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Liu Y; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA., Valtis YK; Department of Medicine, Brigham and Women's Hospital, Boston, MA., Paolino JD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Place AE; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Brunner AM; Center for Leukemia, Massachusetts General Hospital, Boston, MA., Weeks LD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Silverman LB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Vrooman LM; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Neuberg DS; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2023 Apr 11; Vol. 7 (7), pp. 1092-1102.
Autor:
Valtis YK; Department of Medicine, Brigham and Women's Hospital, 75 Francis St, Boston, MA, 02115, USA. yvaltis@bwh.harvard.edu., Stevenson KE; Department of Data Sciences, Dana Farber Cancer Institute, Boston, MA, USA., Murphy EM; Division of Hospital Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Hong JY; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Ali M; Division of Infectious Diseases, Department of Paediatrics, Hospital for Sick Children, Toronto, Canada., Shah S; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA., Taylor A; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA., Sivashanker K; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA.; American Medical Association, Chicago, IL, USA., Shannon EM; Division of General Internal Medicine and Health Services Research, University of California Los Angeles, Los Angeles, CA, USA.
Publikováno v:
Journal of general internal medicine [J Gen Intern Med] 2023 Jan; Vol. 38 (1), pp. 30-35. Date of Electronic Publication: 2022 May 13.
Autor:
Valtis YK; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Place AE; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Pediatric Hematology Oncology, Boston Children's Hospital, Boston, Massachusetts, USA., Silverman LB; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Pediatric Hematology Oncology, Boston Children's Hospital, Boston, Massachusetts, USA., Vrooman LM; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Pediatric Hematology Oncology, Boston Children's Hospital, Boston, Massachusetts, USA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2022 Aug; Vol. 198 (3), pp. 421-430. Date of Electronic Publication: 2022 Mar 21.
Autor:
Valtis YK; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: yvaltis@bwh.harvard.edu., Barlowe T; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Young JH; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Lichtman AH; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Zhao L; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Hornick JL; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Cleary JM; Center of Gastrointestinal Oncology, Dana Farber Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Hashemi N; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Cubre A; Department or Radiology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Baron RM; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Publikováno v:
Clinics and research in hepatology and gastroenterology [Clin Res Hepatol Gastroenterol] 2022 Mar; Vol. 46 (3), pp. 101836. Date of Electronic Publication: 2021 Nov 18.